Profile | GDS5420 / 244790_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 299.72 | 59 |
GSM1296119 | B_lesional_pre-dose | 163.03 | 48 |
GSM1296076 | C_lesional_pre-dose | 135.87 | 48 |
GSM1296092 | D_lesional_pre-dose | 201.61 | 54 |
GSM1296103 | E_lesional_pre-dose | 173.04 | 50 |
GSM1296078 | F_lesional_pre-dose | 168.32 | 51 |
GSM1296107 | G_lesional_pre-dose | 154.86 | 47 |
GSM1296109 | H_lesional_pre-dose | 186.63 | 50 |
GSM1296080 | I_lesional_pre-dose | 358.88 | 62 |
GSM1296090 | J_lesional_pre-dose | 146.76 | 49 |
GSM1296074 | K_lesional_pre-dose | 171.99 | 52 |
GSM1296111 | L_lesional_pre-dose | 122.28 | 43 |
GSM1296099 | M_lesional_pre-dose | 208.49 | 53 |
GSM1296086 | O_lesional_pre-dose | 205.18 | 54 |
GSM1296117 | P_lesional_pre-dose | 185.13 | 50 |
GSM1296113 | Q_lesional_pre-dose | 169.52 | 47 |
GSM1296096 | R_lesional_pre-dose | 231.4 | 55 |
GSM1296105 | S_lesional_pre-dose | 225.87 | 53 |
GSM1296098 | T_lesional_pre-dose | 273.1 | 57 |
GSM1296101 | U_lesional_pre-dose | 156.85 | 48 |
GSM1296121 | V_lesional_pre-dose | 152.96 | 47 |
GSM1296088 | W_lesional_pre-dose | 180.58 | 51 |
GSM1296082 | X_lesional_pre-dose | 137.88 | 48 |
GSM1296115 | Y_lesional_pre-dose | 153.89 | 47 |
GSM1296084 | Z_lesional_pre-dose | 186.02 | 51 |
GSM1296072 | B_lesional_day8 | 165.31 | 48 |
GSM1296069 | L_lesional_day8 | 151.9 | 45 |
GSM1296071 | P_lesional_day8 | 169.21 | 47 |
GSM1296070 | Y_lesional_day8 | 162.97 | 47 |
GSM1296073 | V_lesional_day8 | 153.99 | 48 |
GSM1296034 | A_lesional_day15 | 277.39 | 57 |
GSM1296041 | G_lesional_day15 | 162.75 | 48 |
GSM1296035 | R_lesional_day15 | 214.49 | 54 |
GSM1296038 | U_lesional_day15 | 220.44 | 54 |
GSM1296047 | B_lesional_day15 | 177.94 | 49 |
GSM1296039 | E_lesional_day15 | 134.09 | 46 |
GSM1296042 | H_lesional_day15 | 194.19 | 51 |
GSM1296043 | L_lesional_day15 | 160.45 | 47 |
GSM1296037 | M_lesional_day15 | 165.12 | 48 |
GSM1296046 | P_lesional_day15 | 192.71 | 50 |
GSM1296044 | Q_lesional_day15 | 186.71 | 49 |
GSM1296045 | Y_lesional_day15 | 182.81 | 49 |
GSM1296025 | C_lesional_day15 | 381.88 | 63 |
GSM1296033 | D_lesional_day15 | 235.47 | 55 |
GSM1296027 | I_lesional_day15 | 292.97 | 60 |
GSM1296032 | J_lesional_day15 | 293.37 | 58 |
GSM1296024 | K_lesional_day15 | 489.54 | 67 |
GSM1296031 | W_lesional_day15 | 190.69 | 51 |
GSM1296028 | X_lesional_day15 | 217.5 | 54 |
GSM1296029 | Z_lesional_day15 | 227.68 | 54 |
GSM1296026 | F_lesional_day15 | 155.35 | 49 |
GSM1296030 | O_lesional_day15 | 227.02 | 56 |
GSM1296040 | S_lesional_day15 | 252.07 | 56 |
GSM1296036 | T_lesional_day15 | 311.43 | 59 |
GSM1296048 | V_lesional_day15 | 152.93 | 47 |
GSM1296059 | A_lesional_day43 | 155.96 | 49 |
GSM1296066 | G_lesional_day43 | 194.75 | 51 |
GSM1296060 | R_lesional_day43 | 236.14 | 55 |
GSM1296063 | U_lesional_day43 | 173.52 | 50 |
GSM1296064 | E_lesional_day43 | 150.84 | 49 |
GSM1296067 | H_lesional_day43 | 210.22 | 51 |
GSM1296062 | M_lesional_day43 | 252.14 | 56 |
GSM1296068 | Q_lesional_day43 | 163.69 | 46 |
GSM1296050 | C_lesional_day43 | 249.24 | 56 |
GSM1296057 | D_lesional_day43 | 154.02 | 48 |
GSM1296052 | I_lesional_day43 | 263.14 | 58 |
GSM1296054 | J_lesional_day43 | 358.79 | 61 |
GSM1296049 | K_lesional_day43 | 375.71 | 63 |
GSM1296055 | W_lesional_day43 | 134.81 | 45 |
GSM1296053 | X_lesional_day43 | 234.41 | 55 |
GSM1296058 | Z_lesional_day43 | 133.54 | 47 |
GSM1296051 | F_lesional_day43 | 235.55 | 56 |
GSM1296056 | O_lesional_day43 | 162.36 | 50 |
GSM1296065 | S_lesional_day43 | 161.06 | 48 |
GSM1296061 | T_lesional_day43 | 383.84 | 63 |
GSM1296095 | A_non-lesional_pre-dose | 159.24 | 49 |
GSM1296120 | B_non-lesional_pre-dose | 167.31 | 48 |
GSM1296077 | C_non-lesional_pre-dose | 278.47 | 58 |
GSM1296093 | D_non-lesional_pre-dose | 286.78 | 57 |
GSM1296104 | E_non-lesional_pre-dose | 26.93 | 21 |
GSM1296079 | F_non-lesional_pre-dose | 348.97 | 62 |
GSM1296108 | G_non-lesional_pre-dose | 165.75 | 48 |
GSM1296110 | H_non-lesional_pre-dose | 208.15 | 51 |
GSM1296081 | I_non-lesional_pre-dose | 197.65 | 53 |
GSM1296091 | J_non-lesional_pre-dose | 232.47 | 55 |
GSM1296075 | K_non-lesional_pre-dose | 199.72 | 54 |
GSM1296112 | L_non-lesional_pre-dose | 153.51 | 45 |
GSM1296100 | M_non-lesional_pre-dose | 144.45 | 46 |
GSM1296087 | O_non-lesional_pre-dose | 249.94 | 58 |
GSM1296118 | P_non-lesional_pre-dose | 182.34 | 49 |
GSM1296114 | Q_non-lesional_pre-dose | 128.57 | 43 |
GSM1296097 | R_non-lesional_pre-dose | 210.08 | 53 |
GSM1296106 | S_non-lesional_pre-dose | 174.31 | 49 |
GSM1296102 | U_non-lesional_pre-dose | 257.34 | 55 |
GSM1296122 | V_non-lesional_pre-dose | 137.22 | 45 |
GSM1296089 | W_non-lesional_pre-dose | 158.56 | 48 |
GSM1296083 | X_non-lesional_pre-dose | 198.51 | 52 |
GSM1296116 | Y_non-lesional_pre-dose | 198.86 | 50 |
GSM1296085 | Z_non-lesional_pre-dose | 160.98 | 49 |